QCDx LLC
Farmington, US · Founded 2016 · Connecticut LLC · 1 known investors
QCDx develops liquid biopsy technologies using live 3D imaging to detect and profile circulating tumor cells for cancer diagnosis and drug development. The RareScope platform enables oncologists to optimize treatment strategies and therapeutic agents through single-cell phenotypic analysis of rare cancer cells in early-stage and advanced disease.
Founders & leadership
TT
Triantafyllos TafasManager and Member of Issuer.
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$130KraisedJan 2018 · 3 investors · Other TechnologyRule 506(b)
▶$130KraisedJan 2018 · 3 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Triantafyllos TafasExecutive Officer, Director, Promoter
- Offering amount
- $225K
- Amount sold
- $130K
- First sale
- Dec 2017
- Incorporated
- Limited Liability Company, Connecticut, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- QCDx LLC - Connecticut Innovations Connecticut Innovationsctinnovations.com · 2018